SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
Holding GB:SBTX?
Track your performance easily

SkinBioTherapeutics (SBTX) Cash flow

8 Followers

SkinBioTherapeutics Cash Flow

GB:SBTX's free cash flow for Q2 2023 was £―. For the 2023 fiscal year, GB:SBTX's free cash flow was decreased by £-40.57K and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Operating Cash Flow
-£ -2.65M£ -2.67M£ -1.56M£ -892.14K£ -1.43M
Investing Cash Flow
-£ -165.28K£ -96.81K£ -112.31K£ -73.67K£ -69.40K
Financing Cash Flow
-£ 2.32M£ -35.12K£ 4.12M£ 0.00£ 1.44M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 1.31M£ 1.80M£ 4.61M£ 2.16M£ 3.12M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 2.35M-£ 4.12M£ 0.00£ 1.44M
Issuance Of Debt
-£ -36.10K£ -35.12K---
Repayment Of Debt
-£ -36.10K£ -35.12K---
Free Cash Flow
-£ -2.81M£ -2.77M£ -1.56M£ -965.81K£ -1.50M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

SkinBioTherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis